C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2011
10/13/2011	WO2011124612A1 Specific delivery of agrochemicals
10/13/2011	WO2011124566A1 Antibody recognizing human leukemia inhibitory factor (lif) and use of anti-lif antibodies in the treatment of diseases associated with unwanted cell proliferation
10/13/2011	WO2011124370A1 Fusion protein
10/13/2011	WO2011124071A2 Glycuresis resistant monoclonal antibody
10/13/2011	WO2011106707A3 Antibodies that specifically bind to dr3
10/13/2011	WO2011049412A3 Human recombinant monoclonal antibody that specifically binds to vcam-1 and inhibits adhesion and transmigration between leukocytes and endothelial cells
10/13/2011	WO2011047794A3 Medical utility of glycan-binding proteins and glycans
10/13/2011	WO2010103284A8 Diagnosis and treatment of cell proliferation and differentiation disorders based on the fmn2 gene
10/13/2011	US20110252509 Method for Producing a Transgenic Cell with Increased Gamma-Aminobutyric Acid (Gaba) Content
10/13/2011	US20110252503 Plants With Improved Nitrogen Utilization and Stress Tolerance
10/13/2011	US20110251376 Mammalian Tumor Susceptibility Genes and their Uses
10/13/2011	US20110251375 Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions
10/13/2011	US20110251373 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
10/13/2011	US20110251095 Mara family helix-turn-helix domains and their methods of use
10/13/2011	US20110251090 Pancreatic cancer related gene ttll4
10/13/2011	US20110250702 Isolated peptides of rabbit factor vii
10/13/2011	US20110250701 Novel application of aimp1 polypeptide
10/13/2011	US20110250685 Compositions and methods for enhancing cellular transport of biomolecules
10/13/2011	US20110250681 Fc Variants with Optimized Properties
10/13/2011	US20110250643 Antibody composition-producing cell
10/13/2011	US20110250630 Motif-grafted hybrid polypeptides and uses thereof
10/13/2011	US20110250623 Biomarker and method for detecting a chronic inflammatory-associated disease
10/13/2011	US20110250584 Method for Screening Cancer Therapeutic Agent Using Galectin-3, GSK-3Betta, and Fascin-1
10/13/2011	US20110250222 Antigenic polypeptides of chlamydia-related bacteria for diagnosis and vaccine
10/13/2011	US20110250221 Group A Streptococcus Pharmaceutical Compositions and Methods Thereof
10/13/2011	US20110250218 Disease-Associated Antigens and Methods of Use Thereof
10/13/2011	US20110250216 Methods for killing psma-expressing, taxane-resistant cancer cells
10/13/2011	US20110250214 Drug delivery system toward demyelinating lesion and biochemical marker of demyelinating lesion
10/13/2011	US20110250213 Antibodies to cd122
10/13/2011	US20110250211 Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins
10/13/2011	US20110250210 Neutralizing Antibodies and Fragments Thereof Directed Against Platelet Factor-4 Variant 1 (PF4V1)
10/13/2011	US20110250208 Oxidized Cardiolipin as a Novel Pro-Inflammatory Factor
10/13/2011	US20110250207 Anti-fxi antibodies and methods of use
10/13/2011	US20110250205 Anti-sclerostin antibodies
10/13/2011	US20110250204 Methods and compositions for diagnosing and treating diseases
10/13/2011	US20110250203 Anti-cd5 antibodies
10/13/2011	US20110250202 Reagents, methods, and systems for detecting methicillin-resistant staphylococcus
10/13/2011	US20110250200 Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling
10/13/2011	US20110250199 Immunotoxins and uses thereof
10/13/2011	US20110250195 Antibodies Against IL-25
10/13/2011	US20110250194 Treatment with Anti-ErbB2 Antibodies
10/13/2011	US20110250193 Composition comprising expression or activity inhibitors of ninjurin1 for the prevention and treatment of inflammatory disease
10/13/2011	US20110250165 Antibodies against CXCR4 and Methods of Use Thereof
10/13/2011	US20110250132 Lipoic acid metabolite: useful for drug carrier, nanoparticle conjugate, imaging and hyperthermia therapy
10/13/2011	US20110250130 Tnf-alpha binding proteins
10/13/2011	CA2795938A1 Compositions and methods for providing hematopoietic function
10/13/2011	CA2795831A1 Method for the generation of monoclonal antibodies derived from human b cells
10/13/2011	CA2795734A1 Tnf-.alpha. binding proteins
10/13/2011	CA2795627A1 Compositions and methods for providing hematopoietic function without hla matching
10/13/2011	CA2795480A1 Specific delivery of agrochemicals
10/13/2011	CA2795423A1 Cluap1 peptides and vaccines including the same
10/13/2011	CA2795279A1 Antibodies to cd122
10/13/2011	CA2795200A1 Soluble human st-2 antibodies and assays
10/12/2011	EP2375253A1 Method for assaying all types of influenza viruses
10/12/2011	EP2375251A1 Auxiliary method for diagnosis and therapy of cancer with nucleolin
10/12/2011	EP2374889A2 Novel compounds
10/12/2011	EP2374887A2 Method for isolation of soluble polypeptides
10/12/2011	EP2374886A2 Method for isolation of soluble polypeptides
10/12/2011	EP2374883A1 Anti-cd4 antibody
10/12/2011	EP2374872A2 A method for the high level expression of active lymphotoxin-beta receptor immunoglobulin chimeric proteins and their purification
10/12/2011	EP2374820A2 Human monoclonal antibody having fat-reducing effect
10/12/2011	EP2374819A1 Antibodies to MASP-2
10/12/2011	EP2374818A1 High affinity antibodies to human IL-6 receptor
10/12/2011	EP2374817A1 Anti-P-selectin antibodies
10/12/2011	EP2374816A1 Binding molecules against Chikungunya virus and uses thereof
10/12/2011	EP2374815A1 Canine CD20 compositions
10/12/2011	EP2374811A1 IgG Fc/HIV-gp120/c3d fusion protein
10/12/2011	EP2374001A2 Antibody design using anti-lipid antibody crystal structures
10/12/2011	EP2373786A2 Modulating XRN2
10/12/2011	EP2373785A1 Bovine viral diarrhea virus with a modified erns protein
10/12/2011	EP2373692A1 Dual variable domain immunoglobulins and uses thereof
10/12/2011	EP2373691A2 Anti-fxi antibodies and methods of use
10/12/2011	EP2373690A2 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
10/12/2011	EP2373689A1 Crystals and structure of a human igg fc variant with enhanced fcrn binding
10/12/2011	EP2373688A1 A monoclonal antibody and its use for the identification of the oncofetal isoform of fibronectin (b-fn) for diagnosis or therapy
10/12/2011	EP2373687A2 Antibody variants having modifications in the constant region
10/12/2011	EP2373686A2 Msp2 antigenic peptides and their use
10/12/2011	EP2373676A1 Separation method using single polymer phase systems
10/12/2011	EP2373339A1 A b cell depleting agent for the treatment of atherosclerosis
10/12/2011	EP2373338A2 Annexina2 as immunological target
10/12/2011	EP2373337A1 Monoclonal antibodies directed against lg4-5 domain of alpha3 chain of human laminin-5
10/12/2011	EP2373336A1 Use of an anti-cd20 antibody for treating primary intraocular lymphoma
10/12/2011	EP2373335A1 Anti-ferroportin 1 monoclonal antibodies and uses thereof
10/12/2011	EP2109623B1 Treatment of cancer with anti-il-1 antibodies
10/12/2011	EP1774019B1 Look-through mutagenesis for developing altered polypeptides with enhanced properties
10/12/2011	EP1652923B1 Gene overexpressed in cancer
10/12/2011	EP1570267B1 Assay for identifying antibody producing cells
10/12/2011	EP1191096B1 Ovel protein and dna thereof
10/12/2011	CN102216768A Lcms technology and its uses
10/12/2011	CN102216452A Cell lines and proteins with variant glycosylation pattern
10/12/2011	CN102216333A C-met antibodies
10/12/2011	CN102216332A Use of anti-cs1 antibodies for treatment of rare lymphomas
10/12/2011	CN102216331A Treatment method
10/12/2011	CN102216330A Pharmaceutical compositions of antibodies for diseases caused by viruses
10/12/2011	CN102216329A Treatment of interstitial cystitis
10/12/2011	CN102216328A Antigen binding polypeptides
10/12/2011	CN102216327A Neutralizing anti-influenza a virus antibodies and uses thereof
10/12/2011	CN102215873A Dendritic cell modulatory molecule
10/12/2011	CN102215868A Methods for treating progressive multiple sclerosis
10/12/2011	CN102215867A Composition for treating disease

1 ... 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 ... 1494